Sign inGet started

Gormley Glenn

Insider CIK 2127198 · AKTS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AKTS Aktis Oncology, Inc. A Award deriv2026-04-152026-04-1637,866— $037,866SEC↗